What is the recommended acetazolamide (Diamox) dosing for a traveler without sulfonamide allergy, renal or hepatic disease, or electrolyte disturbances who is ascending to high altitude (≥2,500 m)?

Acetazolamide Dosing for High Altitude Travel

For travelers ascending to ≥2,500 m without contraindications, acetazolamide 125 mg twice daily (250 mg total daily) is the recommended prophylactic dose, started 1-2 days before ascent and continued for 2-4 days at altitude.

Recommended Dosing Regimen

The FDA-approved dosing for acute mountain sickness (AMS) prevention is 250 mg every 8-12 hours or 500 mg extended-release once daily, started before and during rapid ascent 1. However, clinical evidence strongly supports that 125 mg twice daily (250 mg total daily) is equally effective as higher doses with fewer side effects 2, 3.

Specific Dosing Protocol:

• Dose: 125 mg twice daily (morning and evening)
• Start: 1-2 days before ascent (ideally 2 days for optimal acclimatization)
• Duration: Continue through day 2-4 at altitude
• Alternative: Extended-release 500 mg once daily for improved adherence 4

Evidence Supporting Lower Dose

The PACE trial directly compared 125 mg BD versus 375 mg BD and found no significant difference in AMS prevention (24% vs 21% incidence respectively, compared to 51% with placebo), while the lower dose caused significantly less paresthesia 3. A systematic review confirmed that 250 mg daily has similar efficacy to 500-750 mg daily with a more favorable side-effect profile 2. The number needed to treat with 250 mg daily is 6, representing a 48% relative risk reduction compared to placebo 5, 6.

Mechanism and Benefits

Acetazolamide works by inhibiting carbonic anhydrase, which:

• Induces metabolic acidosis that stimulates ventilation
• Improves oxygenation (SpO2 consistently 2-3% higher than placebo) 3, 4
• Reduces periodic breathing during sleep
• Decreases fluid retention through mild diuresis 1

Studies show it reduces AMS incidence from 35-56% to 14-37% depending on ascent profile 7, 4.

Important Clinical Considerations

Contraindications (from FDA labeling):

• Sulfonamide allergy
• Severe renal or hepatic disease
• Hyperchloremic acidosis
• Adrenal insufficiency
• Electrolyte imbalances (particularly hypokalemia, hyponatremia)

Common Side Effects:

• Paresthesias (tingling in fingers/toes) - dose-dependent, more common with higher doses 3
• Polyuria and increased urination
• Altered taste (especially carbonated beverages)
• Generally mild and self-limiting 4

Special Populations:

Cardiovascular patients: Acetazolamide may reduce subendocardial ischemia risk at altitude and is recommended for AMS prevention in cardiac patients (Class IIa recommendation) 8. However, caution is needed when combining with other diuretics due to increased dehydration and electrolyte imbalance risk 8.

Women: May have increased vulnerability to AMS; adequate acclimatization and acetazolamide prophylaxis are particularly important 9.

Practical Algorithm

1. Assess ascent profile: If ascending >500 m/day above 2,500 m or flying directly to ≥3,000 m → recommend prophylaxis
2. Screen for contraindications: sulfa allergy, renal/hepatic disease, electrolyte abnormalities
3. Prescribe: 125 mg PO BID starting 1-2 days pre-ascent, continue 2-4 days at altitude
4. Counsel on: Expected paresthesias, increased urination, importance of hydration, gradual ascent when possible

Key Pitfalls to Avoid

• Don't use excessive doses: 750 mg daily offers no additional benefit over 250 mg daily and causes more side effects 2, 3
• Don't rely solely on medication: Gradual ascent remains the gold standard; acetazolamide is adjunctive
• Don't combine carelessly with other diuretics: Risk of severe dehydration and electrolyte derangement, especially at altitude 8
• Don't forget hydration counseling: The mild diuretic effect requires adequate fluid intake

The 125 mg BID regimen represents the optimal balance of efficacy, safety, and tolerability for AMS prophylaxis in healthy travelers 2, 3.